Detalles de la búsqueda
1.
When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control.
Diabetes Obes Metab
; 21(6): 1305-1310, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724009
2.
EFFICACY AND SAFETY OF IGLARLIXI IN HISPANICS AND NON-HISPANIC WHITES WITH TYPE 2 DIABETES.
Endocr Pract
; 25(11): 1091-1100, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31241362
3.
Low incidence of gastrointestinal adverse events over time with a fixed-ratio combination of insulin glargine and lixisenatide versus lixisenatide alone.
Diabetes Obes Metab
; 20(11): 2690-2694, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29923298
4.
INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES.
Endocr Pract
; 24(2): 143-149, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29106816
5.
When basal insulin is not enough: response to M Davidson.
Diabetes Obes Metab
; 22(4): 711-712, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724245
6.
Alliance for clinical education perspective paper: recommendations for redesigning the "final year" of medical school.
Teach Learn Med
; 26(4): 420-7, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25318040
7.
How persuasive is AI-generated propaganda?
PNAS Nexus
; 3(2): pgae034, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38380055
8.
Contributions of US Medical Schools to Primary Care (2003-2014): Determining and Predicting Who Really Goes Into Primary Care.
Fam Med
; 52(7): 483-490, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640470
9.
Relationships between drug company representatives and medical students: medical school policies and attitudes of student affairs deans and third-year medical students.
Acad Psychiatry
; 33(6): 478-83, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19933893
10.
Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L.
Diabetes Ther
; 10(1): 327, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515716
11.
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
Adv Ther
; 36(9): 2310-2326, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359368
12.
Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L.
Diabetes Ther
; 9(5): 2155-2162, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30218434
13.
Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL.
Endocrinol Diabetes Metab
; 1(4): e00035, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815563
14.
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.
Diabetes Technol Ther
; 19(5): 315-322, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467113
15.
Medical students' exposure to and attitudes about drug company interactions: a national survey.
JAMA
; 294(9): 1034-42, 2005 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-16145023
16.
Changes in medical students' exposure to and attitudes about drug company interactions from 2003 to 2012: a multi-institutional follow-up survey.
Acad Med
; 90(8): 1137-46, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25785675
17.
Peer coaching as a technique to foster professional development in clinical ambulatory settings.
J Contin Educ Health Prof
; 23(1): 30-7, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12739257
18.
Contemporary teaching strategies of exemplary community preceptors--is technology helping?
Fam Med
; 46(10): 776-82, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25646828
Resultados
1 -
18
de 18
1
Próxima >
>>